{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:39:53Z","timestamp":1793090393703,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117195","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T17:48:15Z","timestamp":1734716895000},"page":"117195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dodecyl creatine ester, a promising treatment to deliver creatine to neurons, achieves pharmacology efficacy in creatine transporter deficiency"],"prefix":"10.1016","volume":"284","author":[{"given":"Cl\u00e9mence","family":"Disdier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lhotellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Guyot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narciso","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Th\u00e9odoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pruvost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Joudinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alo\u00efse","family":"Mabondzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-3744","authenticated-orcid":false,"given":"Henri","family":"B\u00e9nech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117195_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1118707","article-title":"Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency","volume":"16","author":"Mabondzo","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117195_bib2","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1021\/jm400545n","article-title":"Synthesis and biological evaluation of new creatine fatty esters revealed dodecyl creatine ester as a promising drug candidate for the treatment of the creatine transporter deficiency","volume":"56","author":"Trotier-Faurion","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117195_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2217\/nnm.13.205","article-title":"Dodecyl creatine ester and lipid nanocapsule: a double strategy for the treatment of creatine transporter deficiency","volume":"10","author":"Trotier-Faurion","year":"2015","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.ejmech.2024.117195_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2217\/nnm-2019-0059","article-title":"Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency","volume":"14","author":"Ullio-Gamboa","year":"2019","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejmech.2024.117195_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/19390211.2013.822453","article-title":"pH-dependent stability of creatine ethyl ester: relevance to oral absorption","volume":"10","author":"Gufford","year":"2013","journal-title":"J. Diet. Suppl."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117195_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020586","article-title":"Creatine supplementation and brain health","volume":"13","author":"Roschel","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ejmech.2024.117195_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gene.2015.04.011","article-title":"Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene","volume":"565","author":"DesRoches","year":"2015","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.ejmech.2024.117195_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11011-018-0197-3","article-title":"Treatment outcome of creatine transporter deficiency: international retrospective cohort study","volume":"33","author":"Bruun","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117195_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4155\/tde-2019-0013","article-title":"Nose-to-brain delivery of biologics","volume":"10","author":"Schwarz","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejmech.2024.117195_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.117195_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/mp1004614","article-title":"In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery","volume":"8","author":"Lacombe","year":"2011","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117195_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016187","article-title":"Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency","volume":"6","author":"Skelton","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2024.117195_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.ejmech.2024.117195_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121227","article-title":"Brain and nasal cavity anatomy of the cynomolgus monkey: species differences from the viewpoint of direct delivery from the nose to the brain","volume":"12","author":"Sakane","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejmech.2024.117195_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cne.21974","article-title":"Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain","volume":"513","author":"Azevedo","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117195_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(98)01261-2","article-title":"Extracellular space structure revealed by diffusion analysis","volume":"21","author":"Nicholson","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2024.117195_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.03.032","article-title":"Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging","volume":"302","author":"Wingrove","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.117195_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jconrel.2021.06.007","article-title":"Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2","volume":"335","author":"Akita","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.117195_bib19","series-title":"Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","year":"2005"},{"key":"10.1016\/j.ejmech.2024.117195_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2024.117195_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.ejmech.2024.117195_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cne.23667","article-title":"Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity","volume":"523","author":"Lowe","year":"2015","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117195_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-023-00634-3","article-title":"Axonal energy metabolism, and the effects in aging and neurodegenerative diseases","volume":"18","author":"Yang","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117195_bib24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2024.117195_bib25","unstructured":"Salomons, G. S.; vanDooren, S. J. M.; Darmin, P.; Verhoeven, N. M.; Marsden, D.; Mancini, G. G. M.; Schwartz, C. E.; Cecil, K. M.; deGrauw, T. J.; Jakobs, C. Novel X-linked mental retardation syndrome: creatine transporter deficiency. Neurology 2004, 62 (7), A22-A22."},{"key":"10.1016\/j.ejmech.2024.117195_bib26","unstructured":"Trevino, J. T.; Quispe, R. C.; Khan, F.; Novak, V. Non-Invasive Strategies for Nose-to-Brain Drug Delivery. J Clin Trials 2020, 10 (7). From NLM."},{"key":"10.1016\/j.ejmech.2024.117195_bib27","doi-asserted-by":"crossref","unstructured":"Fliedner, S.; Schulz, C.; Lehnert, H. Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 2006, 147 (5), 2088-2094. DOI: 10.1210\/en.2005-1016 From NLM.","DOI":"10.1210\/en.2005-1016"},{"key":"10.1016\/j.ejmech.2024.117195_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.nano.2018.10.013","article-title":"Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke","volume":"18","author":"Li","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejmech.2024.117195_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jconrel.2022.09.047","article-title":"Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative","volume":"351","author":"Akita","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.ejmech.2024.117195_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-Brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:33Z","timestamp":1762265253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0223523424010778"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117195","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dodecyl creatine ester, a promising treatment to deliver creatine to neurons, achieves pharmacology efficacy in creatine transporter deficiency","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117195"}}